VOICED : China aprueba "con condiciones" su primera vacuna contra el covid-19

China has conditionally approved the Sinopharm COVID-19 vaccine, claiming 79% efficacy. The approval follows rigorous evaluations, concluding that the vaccine's benefits outweigh potential risks. Conditional marketing allows public access before clinical trials are complete, provided efficacy is indicated. The Health Ministry plans to vaccinate risk groups and aims for 60-70% population immunization. The vaccine will be free for all citizens.

What new insight or understanding did you gain from this video?